| Literature DB >> 9527806 |
R Minami1, C Nakamura, N Inotsume, M Nakano.
Abstract
This study was designed to determine the influence of aluminum hydroxide and famotidine on the bioavailability of tosufloxacin. Coadministration of aluminum hydroxide reduced the bioavailability of tosufloxacin by 31.6% (P < 0.05). Famotidine did not alter tosufloxacin absorption. To avoid potential treatment failures, the concurrent use of tosufloxacin and aluminum hydroxide should be avoided altogether.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9527806 PMCID: PMC105434 DOI: 10.1128/AAC.42.2.453
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191